Dokumendiregister | Terviseamet |
Viit | 8.1-2/24/6218-1 |
Registreeritud | 10.06.2024 |
Sünkroonitud | 11.06.2024 |
Liik | Sissetulev dokument |
Funktsioon | 8.1 Nakkushaiguste seire, ennetuse ja tõrje korraldamine |
Sari | 8.1-2 Nakkushaiguste epidemioloogiaalane riigiväline kirjavahetus |
Toimik | 8.1-2/2024 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | EVD Admin |
Saabumis/saatmisviis | EVD Admin |
Vastutaja | Kärt Sõber (TA, Peadirektori asetäitja (1) vastutusvaldkond, Nakkushaiguste epidemioloogia osakond) |
Originaal | Ava uues aknas |
Saatja: EVD Admin <[email protected]>
Saadetud: 07.06.2024 17:55
Adressaat: mateusz.markowicz <[email protected]>; stephan.aberle
<[email protected]>; tinne.lernout
<[email protected]>; Javiera Rebolledo
<[email protected]>; elica.panayotova
<[email protected]>; iva_trrifonova <[email protected]>;
mikov <[email protected]>; zvjezdana.lovric <[email protected]>;
iva.pem-novosel <[email protected]>; aaristodimou
<[email protected]>; Valentinos Silvestros
<[email protected]>; m.mendris <[email protected]>; mviolaris
<[email protected]>; Hana Orlíková <[email protected]>;
hana.zelena <[email protected]>; Lasse Skafte Vestergaard
<[email protected]>; pvb <[email protected]>; Maria Vikentjeva
<[email protected]>; Jelena Rjabinina
<[email protected]>; pamela.osterlund
<[email protected]>; Liina Voutilainen <[email protected]>;
Marie-Claire PATY <[email protected]>; Henriette
de Valk <[email protected]>; frankc
<[email protected]>; WilkingH <[email protected]>; Danai Pervanidou
<[email protected]>; molnar.zsuzsanna
<[email protected]>; nagy.orsolya <[email protected]>;
Anna Margrét Guðmundsdóttir - Landl
<[email protected]>; Kamilla Sigríður Jósefsdóttir -
Landl <[email protected]>; Paul.McKeown <[email protected]>;
patricia.garvey <[email protected]>; aoife.colgan
<[email protected]>; Riccardo Flavia <[email protected]>;
Federica Ferraro <[email protected]>; Antra Bormane
<[email protected]>; Walser-Domjan Esther <Esther.Walser-
[email protected]>; algirdas.griskevicius <[email protected]>;
Galina Zagrebnevienė <[email protected]>; milda.zygutiene
<[email protected]>; Melillo Tanya at Health Regulation
<[email protected]>; Borg Maria-Louise at Health Regulation <maria-
[email protected]>; Chantal Reusken <[email protected]>; Eelco
Franz <[email protected]>; Elisabeth Astrup <[email protected]>;
Johansen, Tone Kristin Bjordal <[email protected]>; Sadkowska-Todys
Małgorzata <[email protected]>; Paula Vasconcelos <[email protected]
saude.pt>; João Vieira Martins <[email protected]>; Anca
Sirbu <[email protected]>; jana.kerlik <[email protected]>;
edita.staronova <[email protected]>; maja.socan
<[email protected]>; eva.grilc <[email protected]>; Sierra Moros. María
José <[email protected]>; Paz Sánchez-Seco <[email protected]>;
anette.richardson <[email protected]>;
Koopia: NC_CCB_Austria <[email protected]>; sigrid.kiermayr
<[email protected]>; lena.koenig
<[email protected]>; Benka Bernhard
<[email protected]>; koen.blot <[email protected]>;
<[email protected]>; Ruben Brondeel <[email protected]>;
yves.dupont <[email protected]>; Zhivka Getsova
<[email protected]>; Iva Christova <[email protected]>; Nikolay
Bogdanov <[email protected]>; tonyminkova <[email protected]>;
kcapak <[email protected]>; bernard.kaic <[email protected]>;
sanja.kurecicfilipovic <[email protected]>; maja.ilic
<[email protected]>; Elisavet Constantinou <[email protected]>;
Christopher Haralambous <[email protected]>; Valentinos
Silvestros <[email protected]>; <[email protected]>; Hana Orlíková
<[email protected]>; Jan Kynčl <[email protected]>; Kamilla Grønborg
Laut <[email protected]>; Stine Ulendorf Jacobsen <[email protected]>; Sidsel Skou
Voss <[email protected]>; Tyra Grove Krause <[email protected]>; Kärt Sõber
<[email protected]>; TA Info <[email protected]>; Natalia Kerbo
<[email protected]>; Natalia Kerbo
<[email protected]>; Jevgenia Epštein
<[email protected]>; Otto Helve <[email protected]>;
Savolainen-Kopra Carita <[email protected]>; Tuula Hannila-
Handelberg <[email protected]>; Tuija Leino
<[email protected]>; Paula GARCIA-LOBATO <Paula.garcia-
[email protected]>; Anne-Catherine VISO <anne-
[email protected]>; Harold NOEL
<[email protected]>; <[email protected]>; Rexroth, Ute
<[email protected]>; AnderHeidenMa <[email protected]>; BenzlerJ
<[email protected]>; dierckem <[email protected]>; Theodora Kalomama
<[email protected]>; Dimitrios Paraskevis
<[email protected]>; Christakis Chatzichristodoulou
<[email protected]>; k.gkolfinopoulou
<[email protected]>; Kassiani Mellou <[email protected]>;
<[email protected]>; phc.office <[email protected]>; Rezsőfi
Judit <[email protected]>; hajdu.agnes <[email protected]>;
molnar.zsuzsanna <[email protected]>; Guðrún Aspelund - Landl
<[email protected]>; Maríanna Þórðardóttir - Landl
<[email protected]>; Guðrún Aspelund - Landl
<[email protected]>; Anna Margrét Guðmundsdóttir - Landl
<[email protected]>; Greg Martin
<[email protected]>; Kate Loughnane <[email protected]>;
patricia.garvey <[email protected]>; Louise Cullen
<[email protected]>; Lisa.Domegan <[email protected]>; Aine Grace
<[email protected]>; Greg Martin <[email protected]>; Louise Cullen
<[email protected]>; patricia.garvey <[email protected]>;
Lisa.Domegan <[email protected]>; Francesco Maraglino
<[email protected]>; Francesco Maraglino <[email protected]>;
Bonfigli Sandro <[email protected]>; Antra Bormane
<[email protected]>; Jurijs Perevoščikovs
<[email protected]>; Dehler Silvia, Dr. med.
<[email protected]>; Walser-Domjan Esther <Esther.Walser-
[email protected]>; Jurgita Pakalniškienė <[email protected]>;
greta.gargasiene <[email protected]>; Jurgita Pakalniškienė
<[email protected]>; giedre.aleksiene
<[email protected]>; Rasa Liausedienė <[email protected]>;
Jean-Claude Schmit <[email protected]>; Gauci Charmaine at
Health Regulation <[email protected]>; Gauci Charmaine at Health
Regulation <[email protected]>; Melillo Tanya at Health Regulation
<[email protected]>; Hester.de.Melker <[email protected]>;
Susan van den Hof <[email protected]>; Gijs Klous
<[email protected]>; Loes Soetens <[email protected]>; Macdonald,
Emily Ann <[email protected]>; Heidi Lange <[email protected]>;
hilde.klovstad <[email protected]>; Løvlie, Astrid Louise
<[email protected]>; Zacharczuk Katarzyna
<[email protected]>; Sadkowska-Todys Małgorzata <[email protected]>;
Rosińska Magdalena <[email protected]>; Mariana Ferreira
<[email protected]>; Pedro Licinio Pinto Leite
<[email protected]>; <[email protected]>; André Peralta
Santos <[email protected]>; mjalbuquerque
<[email protected]>; Pedro Licinio Pinto Leite
<[email protected]>; Adriana Pistol <[email protected]>;
Anca Sirbu <[email protected]>; Adriana Pistol
<[email protected]>; ecdc <[email protected]>; jan.mikas
<[email protected]>; Mária Avdičová <[email protected]>; jan.mikas
<[email protected]>; <[email protected]>; Marta.vitek
<[email protected]>; eva.grilc <[email protected]>; veronika.ucakar
<[email protected]>; Fernando Simón Soria <[email protected]>;
mvarelam <[email protected]>; <[email protected]>;
<[email protected]>; Agneta Falk Filipsson
<[email protected]>; Sara Bengtsson
<[email protected]>; birgitta.lesko
<[email protected]>; anette.richardson
<[email protected]>; anneli.carlander
<[email protected]>; Anders Lindblom
<[email protected]>; anders.wallensten
<[email protected]>; Celine Gossner
<[email protected]>; Joana Haussig
<[email protected]>; EVD Admin <[email protected]>
Teema: Weekly West Nile Virus Surveillance Report
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu
saatja korral palume linke ja faile mitte avada.
ECDC NORMAL
Dear All,
The first weekly report for West Nile virus surveillance for the year has
been published on the ECDC website. You can access the published report
on the ECDC website through the following link: . Additionally, the
interactive dashboard for West Nile virus transmission is available here:
Thank you for your cooperation.
Regards,
Mohammed
On behalf of the EVD team at ECDC
From: EVD Admin Sent: Friday, May 24, 2024 10:00 AMTo:
'[email protected]' <[email protected]>;
<[email protected]>; '[email protected]'
<[email protected]>;
<[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]' <iva.pem-
[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]' <[email protected]>;
'[email protected]' <[email protected]>; '[email protected]'
<[email protected]>;
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; 'marie-
[email protected]' <marie-
[email protected]>;
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]' <maria-
[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]
saude.pt' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>;
<[email protected]>;
<[email protected]>Cc:
'[email protected]' <[email protected]>;
<[email protected]>;
<[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]' <[email protected]>;
'[email protected]' <[email protected]>; '[email protected]' <[email protected]>;
'[email protected]' <[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; 'anne-
[email protected]' <anne-
[email protected]>;
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]' <[email protected]>;
'[email protected]' <[email protected]>; '[email protected]'
<[email protected]>; '[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
<[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
'[email protected]' <[email protected]>;
<[email protected]>;
'[email protected]' <[email protected]>;
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]' <[email protected]>;
'[email protected]' <[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]' <[email protected]>;
'[email protected]' <[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>; '[email protected]'
<[email protected]>;
<[email protected]>;
<[email protected]>;
<[email protected]>;
<[email protected]>;
<[email protected]>;
<[email protected]>;
<[email protected]>;
<[email protected]>;
<[email protected]>; Celine Gossner
<[email protected]>; Joana Haussig
<[email protected]>; Liese Van Gompel
<[email protected]>; EVD Admin
<[email protected]>Subject: Seasonal surveillance of West
Nile virus infections 2024
To: National Focal Point for Emerging and Vector-borne Diseases, Members
and Alternates
Cc: National Coordinators, National Focal Point for Surveillance, Members
and Alternates
Dear colleagues,
We hope this email finds you well.
As you are probably aware, the first human West Nile virus infection of
2024 has already been reported by Spain, and we plan to begin weekly data
calls from the week 23. We are currently working on some improvements to
the reporting and the dashboard. This year, on a weekly basis, we will
provide a report and a dashboard summarizing the regions reporting human
WNV infections in the EU/EEA and neighbouring countries. Additionally, we
will issue a monthly report that includes more information on and further
analysis of the human data, next to historical data and animal data.
We would like to highlight a few important issues:
The weekly reporting deadline in TESSy for cases to be
included in the update on Friday is Wednesday 20.00 CEST/CET;
We kindly ask you not to change the case IDs during the year;
Please make sure to update the caseID with 2024 in case you
use year numbers in the IDs;
Please report cases that acquired the infection in an
Outermost Region or an EU Overseas Country or Territory as imported;
Thanks and best regards,
For the EVD-team,
Mohammed Afzal
Confidentiality NoticeIf you are not the intended recipient of this
message, you are hereby kindly requested, to, consecutively, refrain from
disclosing its content to any third party, delete it and inform its
sender of the erroneous transmittal.